✨
AI Summary
- ProPublica reporter David Armstrong investigates pharmaceutical pricing after discovering his cancer medication costs $1,000 per pill despite a 25-cent production cost
- Armstrong's investigation of the drug Revlimid reveals pharmaceutical company strategies to eliminate competition and maintain high medication prices
- Discussion of insurance companies denying claims for doctor-recommended tests and treatments, David Bianculli reviews a music documentary about Janis Ian
Guests on This Episode
DA
David Armstrong
1 podcast appearance